| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.538 | 66.118 | 68.842 | 157.711 | 151.428 | 133.244 | 149.209 | 213.428 | 221.810 | 203.056 |
| Total Income - EUR | 27.538 | 66.118 | 68.844 | 157.712 | 155.643 | 133.245 | 178.111 | 216.600 | 229.890 | 232.712 |
| Total Expenses - EUR | 26.703 | 56.581 | 56.484 | 134.324 | 182.134 | 111.089 | 160.923 | 164.924 | 128.802 | 218.985 |
| Gross Profit/Loss - EUR | 835 | 9.537 | 12.360 | 23.388 | -26.490 | 22.156 | 17.188 | 51.676 | 101.088 | 13.727 |
| Net Profit/Loss - EUR | 9 | 8.876 | 11.672 | 21.811 | -28.047 | 20.733 | 15.664 | 48.944 | 99.161 | 6.923 |
| Employees | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 4 | 3 |
Check the financial reports for the company - Davlon Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.149 | 12.337 | 16.660 | 38.647 | 33.742 | 67.301 | 49.388 | 35.381 | 70.709 | 163.998 |
| Current Assets | 12.242 | 14.513 | 18.642 | 20.110 | 16.210 | 44.869 | 74.897 | 103.836 | 170.410 | 138.345 |
| Inventories | 1.798 | 2.052 | 1.852 | 0 | 0 | 731 | 0 | 0 | 0 | 0 |
| Receivables | 6.785 | 7.142 | 10.373 | 14.669 | 16.160 | 35.912 | 19.989 | 54.825 | 154.433 | 135.532 |
| Cash | 3.658 | 5.319 | 6.417 | 5.440 | 51 | 8.226 | 54.908 | 49.010 | 15.977 | 2.813 |
| Shareholders Funds | 2.169 | 11.032 | 22.518 | 43.916 | 15.018 | 35.467 | 50.345 | 64.704 | 163.669 | 12.871 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 32.338 | 23.433 | 12.784 | 14.841 | 34.934 | 76.703 | 73.941 | 74.512 | 77.450 | 342.873 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Davlon Med Srl